Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy-Reference-Cited by-同舟云学术

Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy

Published:2006-07 Issue:5 Volume:7 Page:311-316
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Moore DM,Hogg RS,Yip B,Wood E,Harris M,Montaner JSG

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2006.00381.x/fullpdf

Reference17 articles.

1. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

2. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population

3. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS

4. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

5. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis;BMC Infectious Diseases;2015-10-26

2. Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS;Cochrane Database of Systematic Reviews;2013-03-28

3. Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial;AIDS Care;2010-12

4. A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS;Cochrane Database of Systematic Reviews;2009-07-08

5. Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment;Journal of Clinical Investigation;2009-03-16